Return to content in this issue
Excipients as potential agents of anaphylaxis in vaccines: analyzing the formulations of the current authorized COVID-19 vaccines
Caballero ML, Quirce S
Department of Allergy, La Paz University Hospital, IdiPAZ, Madrid, Spain.
J Investig Allergol Clin Immunol 2021; Vol. 31(1)
Key words: Allergy, Anaphylaxis, Coronavirus, COVID-19, Drug immediate hypersensitivity reaction, Excipient, Pharmaceutical excipients, Vaccine